|
Form Serial Number: |
DA20200131E00183 (Amendment to DA20200129E00271)
|
1.
Date of relevant event: |
23/01/2020 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
00660 |
4.
Name of listed corporation: |
Wai Chun Bio-Technology Ltd. |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
16,590,685,376 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
LAM |
(Other names) |
CHING KUI |
|
|
|
10.
Name of director (Chinese): |
林清渠 |
11.
Chinese Character Code as printed on HKID Card: |
265132373255 |
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1113 | The number of shares in which you are interested has increased because: any other event (you must briefly describe the relevant event in the Supplementary Information box) | |
|
2201 | Interest of corporation controlled by you | |
1,360,659,506 |
HKD |
|
|
0.0324 |
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 8,431,364,320 | 50.82 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 9,792,023,826 | 59.02 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
2201 | Interest of corporation controlled by you |
| Long position | 9,475,683,826 |
|
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4107 | Unlisted derivatives - Convertible instruments |
| | | | | | | | | 1,360,659,506 |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
Wai Chun Investment Fund | Vistra (Cayman) Limited, P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1-1205 Cayman Islands | Lam Ching Kui | 100.00 | N | Long position | 9,475,683,826 |
|
Chinese Success Limited | P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands | Wai Chun Investment Fund | 100.00 | Y | Long position | 9,475,683,826 |
|
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
On 23 January 2020, the Wai Chun Bio-Technology Ltd entered into the Subscription Agreement with Chinese Success pursuant to which Chinese Success conditionally agreed to subscribe for and the Company conditionally agreed to issue the Convertible Bonds in the principal amount of HK$44,085,368. (Conversion Price of HK$0.0324). Assuming the Conversion Rights are exercised in full at the Conversion Price, 1,360,659,506 new Shares, may be allotted and issued to Chinese Success.
|
35.
Log/Serial Number of the previous form: |
DA20200129E00271
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
31/01/2020 (dd/mm/yyyy)
|
|